Speaker illustration

Ms Yongping Qiao

(China)

Real-world early effectiveness and safety of inclisiran in China Pilot Zone: An interim analysis of 3-month data from a prospective non-interventional cohort study

Event: ESC Preventive Cardiology 2023

Topic: Lipid-Lowering Agents

Session: Late-Breaking Science session

Thumbnail

ESC 365 is supported by